Lindbrook Capital’s Hims & Hers Health HIMS Stock Holding History

Lindbrook Capital’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$18.6K	Buy	631 +214	+51%	+$7.95K	﹤0.01%	1386
2024 Q4	$10.1K	Buy	417 +51	+14%	+$1.26K	﹤0.01%	1644
2024 Q3	$6.74K	Sell	366 -123	-25%	-$2.2K	﹤0.01%	1874
2024 Q2	$9.87K	Buy	489 +140	+40%	+$2.33K	﹤0.01%	1637
2024 Q1	$5.4K	Hold	349	–	–	﹤0.01%	1864
2023 Q4	$3.11K	Buy	349 +101	+41%	+$747	﹤0.01%	2100
2023 Q3	$1.56K	Hold	248	–	–	﹤0.01%	2204
2023 Q2	$2.33K	Sell	248 -65	-21%	-$644	﹤0.01%	2097
2023 Q1	$3.1K	Buy	313 +35	+13%	+$307	﹤0.01%	2058
2022 Q4	$1.78K	Buy	278 +44	+19%	+$250	﹤0.01%	2278
2022 Q3	$1K	Buy	+234	New	+$1.41K	﹤0.01%	2344
2022 Q1	–	Sell	-1,200	Closed	-$8K	–	2533
2021 Q4	$8K	Hold	1,200	–	–	﹤0.01%	1358
2021 Q3	$9K	Buy	1,200 +700	+140%	+$5.93K	﹤0.01%	1030
2021 Q2	$5K	Sell	500 -580	-54%	-$6.9K	﹤0.01%	1285
2021 Q1	$14K	Buy	+1,080	New	+$18.1K	﹤0.01%	875

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Lindbrook Capital's HIMS Position: Q1 2025 in Review

Lindbrook Capital increased its Hims & Hers Health (HIMS) stake by 51% in Q1 2025, buying an estimated $7.95K and bringing the position to 631 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1386.

Lindbrook Capital first reported a position in HIMS in Q1 2021 and has held it in 15 quarters since. 429 funds tracked by Wall St. Rank hold HIMS as of Q1 2025.

Lindbrook Capital held 631 shares of Hims & Hers Health worth $18.6K as of Q1 2025.
Lindbrook Capital bought 214 Hims & Hers Health shares in Q1 2025, an estimated $7.95K.
Hims & Hers Health made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1386 holding.
Lindbrook Capital first reported a position in Hims & Hers Health in Q1 2021 and has held it in 15 quarters since.
429 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.